Current and future treatment options for polycythemia vera

por Griesshammer, Martin, Gisslinger, Heinz, Mesa, Ruben
Publicado 2015

The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion

por Barbui, Tiziano, Thiele, Jürgen, Gisslinger, Heinz, Kvasnicka, Hans Michael, Vannucchi, Alessandro M., Guglielmelli, Paola, Orazi, Attilio, Tefferi, Ayalew
Publicado 2018

Acute oxygenator occlusion in two cases of polycythemia vera: Bailout strategies

por Kaiser, Philipp, Zuckermann, Andreas, Horvat, Johann, Lederer, Franz, Gisslinger, Heinz, Gremmel, Franz, Simon, Paul, Wiedemann, Dominik, Andreas, Martin
Publicado 2020

Long non-coding RNAs display higher natural expression variation than protein-coding genes in healthy humans

por Kornienko, Aleksandra E., Dotter, Christoph P., Guenzl, Philipp M., Gisslinger, Heinz, Gisslinger, Bettina, Cleary, Ciara, Kralovics, Robert, Pauler, Florian M., Barlow, Denise P.
Publicado 2016

Impact of platelets on major thrombosis in patients with a normal white blood cell count in essential thrombocythemia

por Buxhofer‐Ausch, Veronika, Wolf, Dominik, Sormann, Siegfried, Forjan, Ernst, Schimetta, Wolfgang, Gisslinger, Bettina, Heibl, Sonja, Krauth, Maria Theresa, Thiele, Jürgen, Ruckser, Reinhard, Gisslinger, Heinz
Publicado 2020

Elotuzumab, pomalidomide, and dexamethasone is a very well tolerated regimen associated with durable remission even in very advanced myeloma: a retrospective study from two academi...

por Hose, Dorothea, Schreder, Martin, Hefner, Jochen, Bittrich, Max, Danhof, Sophia, Strifler, Susanne, Krauth, Maria-Theresa, Schoder, Renate, Gisslinger, Bettina, Einsele, Hermann, Gisslinger, Heinz, Knop, Stefan
Publicado 2020

Essential thrombocythemia vs. pre-fibrotic/early primary myelofibrosis: discrimination by laboratory and clinical data

por Schalling, Martin, Gleiss, Andreas, Gisslinger, Bettina, Wölfler, Albert, Buxhofer-Ausch, Veronika, Jeryczynski, Georg, Krauth, Maria-Theresa, Simonitsch-Klupp, Ingrid, Beham-Schmid, Christine, Thiele, Jürgen, Gisslinger, Heinz
Publicado 2017

Myelomonocytic Skewing In Vitro Discriminates Subgroups of Patients with Myelofibrosis with A Different Phenotype, A Different Mutational Profile and Different Prognosis

por Geissler, Klaus, Gisslinger, Bettina, Jäger, Eva, Jäger, Roland, Schiefer, Ana-Iris, Bogner, Edith, Fuchs, Elisabeth, Schischlik, Fiorella, Alpar, Donat, Simonitsch-Klupp, Ingrid, Kralovics, Robert, Gisslinger, Heinz
Publicado 2020

Increased resting heart rate and prognosis in treatment‐naïve unselected cancer patients: results from a prospective observational study

por Anker, Markus S., Frey, Maria K., Goliasch, Georg, Bartko, Philipp E., Prausmüller, Suriya, Gisslinger, Heinz, Kornek, Gabriela, Strunk, Guido, Raderer, Markus, Zielinski, Christoph, Hülsmann, Martin, Pavo, Noemi
Publicado 2020

The circulating form of neprilysin is not a general biomarker for overall survival in treatment-naïve cancer patients

por Pavo, Noemi, Arfsten, Henrike, Cho, Anna, Goliasch, Georg, Bartko, Philipp E., Wurm, Raphael, Freitag, Claudia, Gisslinger, Heinz, Kornek, Gabriela, Strunk, Guido, Raderer, Markus, Zielinski, Christoph, Hülsmann, Martin
Publicado 2019

Survival expectation after thrombosis and overt-myelofibrosis in essential thrombocythemia and prefibrotic myelofibrosis: a multistate model approach

por Carobbio, Alessandra, Vannucchi, Alessandro Maria, Rumi, Elisa, De Stefano, Valerio, Rambaldi, Alessandro, Carli, Giuseppe, Randi, Maria Luigia, Gisslinger, Heinz, Passamonti, Francesco, Thiele, Juergen, Gangat, Naseema, Tefferi, Ayalew, Barbui, Tiziano
Publicado 2023

GDF‐15 in solid vs non‐solid treatment‐naïve malignancies

por Arfsten, Henrike, Cho, Anna, Freitag, Claudia, Raderer, Markus, Goliasch, Georg, Bartko, Philipp E., Wurm, Raphael, Strunk, Guido, Gisslinger, Heinz, Marosi, Christine, Kornek, Gabriela, Zielinski, Christoph, Hülsmann, Martin, Pavo, Noemi
Publicado 2019

Ruxolitinib therapy for myelofibrosis in Austria: Consensus on therapy management

por Krauth, Maria-Theresa, Burgstaller, Sonja, Buxhofer-Ausch, Veronika, Gastl, Günther, Geissler, Klaus, Keil, Felix, Krippl, Peter, Melchardt, Thomas, Petzer, Andreas, Rumpold, Holger, Sliwa, Thamer, Wöhrer, Stefan, Wölfler, Albert, Gisslinger, Heinz
Publicado 2018

EXPAND, a dose-finding study of ruxolitinib in patients with myelofibrosis and low platelet counts: 48-week follow-up analysis

por Vannucchi, Alessandro M., te Boekhorst, Peter A. W., Harrison, Claire N., He, Guangsheng, Caramella, Marianna, Niederwieser, Dietger, Boyer-Perrard, Françoise, Duan, Minghui, Francillard, Nathalie, Molloy, Betty, Wroclawska, Monika, Gisslinger, Heinz
Publicado 2019

Ropeginterferon alpha-2b targets JAK2V617F-positive polycythemia vera cells in vitro and in vivo

por Verger, Emmanuelle, Soret-Dulphy, Juliette, Maslah, Nabih, Roy, Lydia, Rey, Jerome, Ghrieb, Zineb, Kralovics, Robert, Gisslinger, Heinz, Grohmann-Izay, Barbara, Klade, Christoph, Chomienne, Christine, Giraudier, Stéphane, Cassinat, Bruno, Kiladjian, Jean-Jacques
Publicado 2018

The use of erythropoiesis-stimulating agents with ruxolitinib in patients with myelofibrosis in COMFORT-II: an open-label, phase 3 study assessing efficacy and safety of ruxolitini...

por McMullin, Mary Frances, Harrison, Claire N., Niederwieser, Dietger, Demuynck, Hilde, Jäkel, Nadja, Gopalakrishna, Prashanth, McQuitty, Mari, Stalbovskaya, Viktoriya, Recher, Christian, Theunissen, Koen, Gisslinger, Heinz, Kiladjian, Jean-Jacques, Al-Ali, Haifa-Kathrin
Publicado 2015

Inflammation-Based Scores as a Common Tool for Prognostic Assessment in Heart Failure or Cancer

por Arfsten, Henrike, Cho, Anna, Prausmüller, Suriya, Spinka, Georg, Novak, Johannes, Goliasch, Georg, Bartko, Philipp E., Raderer, Markus, Gisslinger, Heinz, Kornek, Gabriela, Köstler, Wolfgang, Strunk, Guido, Preusser, Matthias, Hengstenberg, Christian, Hülsmann, Martin, Pavo, Noemi
Publicado 2021

Iron metabolism and iron supplementation in cancer patients

por Ludwig, Heinz, Evstatiev, Rayko, Kornek, Gabriela, Aapro, Matti, Bauernhofer, Thomas, Buxhofer-Ausch, Veronika, Fridrik, Michael, Geissler, Dietmar, Geissler, Klaus, Gisslinger, Heinz, Koller, Elisabeth, Kopetzky, Gerhard, Lang, Alois, Rumpold, Holger, Steurer, Michael, Kamali, Houman, Link, Hartmut
Publicado 2015

Erratum to: Iron metabolism and iron supplementation in cancer patients

por Ludwig, Heinz, Evstatiev, Rayko, Kornek, Gabriela, Aapro, Matti, Bauernhofer, Thomas, Buxhofer-Ausch, Veronika, Fridrik, Michael, Geissler, Dietmar, Geissler, Klaus, Gisslinger, Heinz, Koller, Elisabeth, Kopetzky, Gerhard, Lang, Alois, Rumpold, Holger, Steurer, Michael, Kamali, Houman, Link, Hartmut
Publicado 2015

P1034: FROM SNAPSHOT TO CONTINUUM: CUMULATIVE TIME IN RESPONSE AS AN EMERGING PROXY FOR THROMBOTIC RISK IN POLYCYTHEMIA VERA

por Gisslinger, Heinz, Klade, Christoph, Georgiev, Pencho, Krochmalczyk, Dorota, Gercheva-Kyuchukova, Liana, Egyed, Miklos, Dulicek, Petr, Illes, Arpad, Pylypenko, Halyna, Sivcheva, Lylia, Mayer, Jiří, Yablokova, Vera, Krejcy, Kurt, Empson, Victoria, Hasselbalch, Hans C., Kralovics, Robert, Kiladjian, Jean-Jacques
Publicado 2023